Private equity giant Trilantic North America raises $2.75 billion
The funds will seek opportunities in the business services, consumer and energy sectors
The Trilantic Capital Partners VI (North America) and its parallel fund named Fund VI North America announced they raised $2.75 billion for the latter. The fund closed at its hard cap limit.
The positive response can be gauged from the fact that over 75% of the capital commitments came from existing investors. These comprise a host of entities such as pensions, insurance companies, corporates, family offices, endowments and HNIs. There were also new investors, located both in the US and overseas.
Fund VI North America also overtook in size its $2.25 billion predecessor fund.
Trilantic Capital Partners and entrepreneurialism
“We will continue into the next decade investing in entrepreneurial and family- and founder-owned businesses, supporting exceptional management teams that offer products and services with high potential for growth,” said Charlie Ayres, Chairman, Trilantic.
Fund VI North America has invested in Sunbelt Transformer, Planet Fitness franchisor Taymax and DJR Energy.
Earlier this month, Trilantic North America sold its majority stake in Home Franchise Concepts, a leading franchising system in the home improvement goods and services space, to JM Family Enterprises, Inc.
Of course, Trilantic Capital Partners will have a hard time keeping up with groups like Blackstone. The largest private equity manager in the world will likely raise $100 billion in 2019.
Latest Alternative Investment News
Jeremiah Gordon is General Counsel at CapitalG, Alphabet’s (NASDAQ: GOOGL) independent growth fund which has $3 billion under management. He also leads an Alphabet-wide team focused on investing in Black-led…
Though initial reports said that Colonial Pipeline would not pay a ransom to the hackers that brought the nation’s largest fuel pipeline to a halt, Bloomberg reported Thursday that the…
Artificial Intelligence: A Molecule For Alzheimer’s Created By Exscientia’s AI Enters Clinical Trials
Oxford, UK-based Exscientia uses AI to design and create drug candidate molecules satisfying complex therapeutic requirements with revolutionary efficiency. Joint research by Exscientia with Sumitomo Dainippon Pharma Co., Ltd. (TYO:…
Vinted, a European startup that runs a marketplace for used clothing and home goods, announced its raise of $303 million at a valuation of $4.5 billion, post-money. That valuation is…